2023 MGMS Lecture Tour & AGM

All MGMS Seminars are free of charge and open to all.
Please register below to attend this event.


The MGMS was formed in 1981 to bring together scientists working in different fields of study—such as chemistry, physics, biology, mathematics and computer science—who have a common interest in computational molecular modelling and molecular graphics. One of our activities is to organize MGMS Lecture Tours to highlight cutting-edge research in the field.

We are pleased to announce that Andrew Hopkins, CEO of Exscientia will be giving a virtual MGMS Lecture Tour lecture on 29th of September 2023 via Zoom. The lecture tour will follow talks from two previous MGMS Frank Blaney Award Winners, Albert J. Kooistra from University of Copenhagen (awarded in 2021) and Kristaps Ermanis from University of Nottingham (awarded in 2022). The MGMS Lecture Tour will be followed by the MGMS AGM.

Please register below to attend. 

Zoom connection details have been now sent to everyone registered so far – if you have not received them please check your “Spam” folder, or contact us on secretary@mgms.org

Friday, September 29th, 2023

About Speakers


Andrew Hopkins

Chief Executive Officer, Exscientia

Andrew Hopkins is the Founder and Chief Executive of Exscientia plc, where he has pioneered the use of artificial intelligence and machine learning to design new medicines.

Andrew led the teams that discovered the first drugs to enter human clinical trials which were designed with the extensive use of machine learning and AI generative methods. Exscientia plc listed on the NASDAQ in October 2021 and is recognised as the most successful UK university spin out company of the past decade. For its end-to-end AI-driven precision medicine platform, Exscientia won the Prix Galien USA for Digital Health in 2022 and the Prix Galien UK in the same category in 2023.

Andrew holds an honorary Professorship at the University of Dundee, where he previously held the Chairs of Medicinal Informatics and Translational Biology. He served as the Director of the Scottish Universities Life Science Alliance and co-founded the European Lead Factory. Prior to the University of Dundee, he spent a decade at Pfizer leading various informatics groups. Andrew received his DPhil in biophysics from the University of Oxford and LLD from the University of Dundee.


Albert J Kooistra

Assistant Professor, University of Copenhagen

Albert was awarded his PhD by VU Amsterdam in 2015, and since 2018 has been based at the Department of Drug Design and Pharmacology in Copenhagen. His work concerns the structures and properties of G-Protein Coupled Receptors (GPCRs), a key class of macromolecules which are embedded in membranes and thereby can govern access for smaller molecules to and from the cells. Alberts leads the team of developers of GPCRdb, a database (with accompanying search and display tools) of GPCRs which curates sequence alignments, structures, and known mutations, and which is therefore useful for anyone studying GPCR function or targeting GPCRs in drug design. Albery has produced a similar resource for protein kinases, KLIFS.


Kristaps Ermanis

Assistant Professor, University of Nottingham

Kristaps Ermanis is an Assistant Professor in the School of Chemistry at the University of Nottingham. He was appointed in 2021, having held a Leverhulme Early Career Fellowship at the University of Cambridge from 2017. Originally, he trained as a synthetic organic chemist, completing a PhD at the University of York on the total synthesis of phorboxazole B. His current research at Nottingham is focused on automation and scale-up of computational methods, enabling large dataset generation and the computational design and discovery of new synthetic reactions. For more information about Kristaps’ research at Nottingham please visit the group website.



In case of any problems with registration please contact us directly on: secretary@mgms.org